Articles from BeOne Medicines and CLL Society
CLL Society and BeOne Medicines Announce Expanded Partnership to Advance Education and Support Across the CLL/SLL Community
CLL Society, a leading authority for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) patients, and BeOne Medicines, a global oncology company, today announced an expanded, multi-year partnership focused on strengthening education, engagement, and access to trusted resources across the CLL/SLL community.
By BeOne Medicines and CLL Society · Via Business Wire · November 17, 2026
